Houston, United States
NuProbe, founded in 2016, is a biotechnology startup headquartered in the United States. The company specializes in the development and validation of high-sensitivity genomics panels. Their focus is on challenging DNA biomarkers such as CNVs, gene fusions, and low-frequency mutations.
Positioned within the vibrant Biotechnology and Health Care industries, NuProbe distinguishes itself with the ability to tackle intricate genetic anomalies, providing solutions tailored to cutting-edge genomic research and diagnostics.
Remarkably, the company secured a substantial $50.00M Series B investment on 02 June 2022. This funding round was supported by a strong consortium of investors, including Pappas Capital, BioTrack Capital, 上海涌铧投资管理有限公司, Sequoia Capital China, Pan-Lin Capital, CR-CP Life Science Fund, Deguan Capital, Haoreng Capital, and CICC Healthcare Investment Fund.
As an analyst, the company's robust investment backing and specialized focus suggest strong potential for growth and impact in the genomics sector.
YVC Ventures Private Limited